Pamela S. Ohashi

Prof. Pamela S. Ohashi


Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2008 in Cytokine
Verified
Journal Article
Closed access
YLYong-Chen Lu
Yong-Chen Lu
WYWen-Chen Yeh
Wen-Chen Yeh
POPamela S. Ohashi
Pamela S. Ohashi

1 November 1999 in Nature
Verified
Journal Article
Closed access
PDF file
YKYoung-Yun Kong
Young-Yun Kong
UFUlrich Feige
Ulrich Feige
ISIidiko Sarosi
Iidiko Sarosi
BBBrad Bolon
Brad Bolon
ATAnna Tafuri
Anna Tafuri
JPJosef M Penninger
Josef M Penninger

1 May 1993 in Cell
Verified
Journal Article
Closed access
KPKlaus Pfeffer
Klaus Pfeffer
TMToshifumi Matsuyama
Toshifumi Matsuyama
TKThomas M. Kündig
Thomas M. Kündig
AWAndrew Wakeham
Andrew Wakeham
KKKenji Kishihara
Kenji Kishihara
TMTak W. Mak
Tak W. Mak

3 October 2013 in The Journal of Pathology
Verified
Journal Article
Open access
PDF file
JGJerome Galon
Jerome Galon
BMBernhard Mlecnik
Bernhard Mlecnik
GBGabriela Bindea
Gabriela Bindea
HAHelen K Angell
Helen K Angell
ABAnne Berger
Anne Berger
FPFranck Pagès
Franck Pagès
The American Joint Committee on Cancer/Union Internationale Contre le Cancer (AJCC/UICC) TNM staging system provides the most reliable guidelines for the routine prognostication and treatment of colorectal carcinoma. This traditional tumour staging summarizes data on tumour burden (T), the presence of cancer cells in draining and regional lymph nodes (N) and evidence for distant metastases (M). However, it is now recognized that the clinical outcome can vary significantly among patients within the same stage. The current classification provides limited prognostic information and does not predict response to therapy. Multiple ways to classify cancer and to distinguish different subtypes of colorectal cancer have been proposed, including morphology, cell origin, molecular pathways, mutation status and gene expression‐based stratification. These parameters rely on tumour‐cell characteristics. Extensive literature has investigated the host immune response against cancer and demonstrated the prognostic impact of the in situ immune cell infiltrate in tumours. A methodology named ‘Immunoscore’ has been defined to quantify the in situ immune infiltrate. In colorectal cancer, the Immunoscore may add to the significance of the current AJCC/UICC TNM classification, since it has been demonstrated to be a prognostic factor superior to the AJCC/UICC TNM classification. An international consortium has been initiated to validate and promote the Immunoscore in routine clinical settings. The results of this international consortium may result in the implementation of the Immunoscore as a new component for the classification of cancer, designated TNM‐I (TNM‐Immune). © 2013 The Authors. Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

30 July 1993 in Science
Verified
Journal Article
Closed access
PDF file
ASArda Shahinian
Arda Shahinian
KPKlaus Pfeffer
Klaus Pfeffer
KLKelvin P. Lee
Kelvin P. Lee
TKThomas M. Kündig
Thomas M. Kündig
KKKenji Kishihara
Kenji Kishihara
TMTak W. Mak
Tak W. Mak
T cell receptor stimulation without costimulation is insufficient for the induction of an optimal immune response. It is thought that engagement of the CD28 molecule with its ligand B7 provides an essential costimulatory signal without which full activation of T cells cannot occur. A mouse strain with a defective CD28 gene was established. Development of T and B cells in the CD28-deficient mice appeared normal. However, T lymphocytes derived from CD28 -/- mutant mice had impaired responses to lectins. Lectin stimulation did not trigger interleukin-2 (IL-2) production, IL-2 receptor α expression was significantly decreased, and exogenous IL-2 only partially rescued the CD28 defect. Basal immunoglobulin (Ig) concentrations in CD28-deficient mice were about one-fifth of those found in wild-type controls, with low titers of IgG1 and IgG2b but an increase in IgG2a. In addition, activity of T helper cells in CD28 -/- mice was reduced and immunoglobulin class switching was diminished after infection with vesicular stomatitis virus. However, cytotoxic T cells could still be induced and the mice showed delayed-type hypersensitivity after infection with lymphocytic choriomeningitis virus. Thus, CD28 is not required for all T cell responses in vivo, suggesting that alternative costimulatory pathways may exist.

1 April 1991 in Cell
Verified
Journal Article
Closed access
POPamela S. Ohashi
Pamela S. Ohashi
SOStephan Oehen
Stephan Oehen
KBKurt Buerki
Kurt Buerki
HPHanspeter Pircher
Hanspeter Pircher
COCara T. Ohashi
Cara T. Ohashi
HHHans Hengartner
Hans Hengartner